CAROL CHRISTENSEN: Open Payments
NPI 1801190988 · SPRINGFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 30 payments from 6 companies in 2025. Trend: 2023 $356 · 2024 $308 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $273 |
| Gilead Sciences, Inc. | 8 | $229 |
| Madrigal Pharmaceuticals | 2 | $111 |
| PFIZER INC. | 1 | $32 |
| Celltrion USA Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: Livdelzi, REZDIFFRA, RINVOQ, CREON, SKYRIZI, MAVYRET, VELSIPITY, VEGZELMA.
Industry payments across OH — which companies pay providers there.
